Srs Capital Advisors, Inc. Intra Cellular Therapies, Inc. Transaction History
Srs Capital Advisors, Inc.
- $901 Million
- Q1 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 19 shares of ITCI stock, worth $1,407. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19
Previous 19
-0.0%
Holding current value
$1,407
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ITCI
# of Institutions
382Shares Held
77.7MCall Options Held
1.7MPut Options Held
1.13M-
Vanguard Group Inc Valley Forge, PA9.23MShares$683 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.08MShares$598 Million0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$286 Million1.4% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.82MShares$209 Million3.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.48MShares$183 Million2.06% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $6.99B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...